title: Dobutamine-induced myoclonia in severe renal failure.
authors.forename: Laurence
authors.initials: L
authors.lastname: Wierre
authors.forename: Bertrand
authors.initials: B
authors.lastname: Decaudin
authors.forename: Joseph
authors.initials: J
authors.lastname: Barsumau
authors.forename: Marie X
authors.initials: MX
authors.lastname: Vairon
authors.forename: Sandrine
authors.initials: S
authors.lastname: Horrent
authors.forename: Pascal
authors.initials: P
authors.lastname: Odou
authors.forename: Raymond
authors.initials: R
authors.lastname: Azar
mesh_terms: D000368:Aged; D002316:Cardiotonic Agents / Q000009:adverse effects*; D004280:Dobutamine / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology; D008297:Male; D009207:Myoclonus / Q000139:chemically induced*
chemical_list: D002316:Cardiotonic Agents; D004280:Dobutamine